SCP & CO Healthcare Acquisition Company Class A Common Stock
SHAC
SHAC was delisted on the 9th of December, 2022.
69 hedge funds and large institutions have $206M invested in SCP & CO Healthcare Acquisition Company Class A Common Stock in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 6 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 9
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
1% more capital invested
Capital invested by funds: $205M → $206M (+$1.73M)
0% more funds holding
Funds holding: 69 → 69 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Cantor Fitzgerald
New York
|
+$2.95M |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
+$2M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$1.93M |
| 4 |
D.E. Shaw & Co
New York
|
+$1.33M |
| 5 |
SCM
Saba Capital Management
New York
|
+$1.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$4.93M |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$1.37M |
| 3 |
CCM
Context Capital Management
Lajolla,
California
|
-$734K |
| 4 |
CM
Crestline Management
Fort Worth,
Texas
|
-$504K |
| 5 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$491K |
SHAC Hedge Fund Activity: Q2 2022 in Review
69 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) for Q2 2022, worth a combined $206M — up 0.85% from $205M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new SHAC positions and 6 closed out — a net gain of 1 holder — while 15 added to existing stakes and 9 trimmed.
The largest buyer was Cantor Fitzgerald, opening a new position worth an estimated $2.95M. The largest seller was Citadel Advisors, cutting an estimated $4.93M.
- 69 institutional investors held SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $206M of SCP & CO Healthcare Acquisition Company Class A Common Stock stock for Q2 2022, up 0.85% quarter-over-quarter.
- 7 funds opened new SCP & CO Healthcare Acquisition Company Class A Common Stock positions in Q2 2022 and 6 closed out, a net change of +1 holder.
- The largest SCP & CO Healthcare Acquisition Company Class A Common Stock buyer in Q2 2022 was Cantor Fitzgerald, an estimated $2.95M added.
- The largest SCP & CO Healthcare Acquisition Company Class A Common Stock seller in Q2 2022 was Citadel Advisors, an estimated $4.93M sold.
Based on aggregated 13F filings for Q2 2022.